RWJ-56110 dihydrochloride

RWJ-56110 dihydrochloride 是一种有效的、选择性的拟肽抑制剂,可抑制 PAR-1 激活和内化(结合 IC50=0.44 uM),对 PAR-2、PAR-3 和 PAR-4 无影响,并能抑制由 SFLLRN-NH2(IC50=0.16 μM)和凝血酶(IC50=0.34 μM)诱导的血小板聚集,相对于 U46619(MS-O09517)具有相当的选择性,同时在体内阻断血管生成和新血管形成,并诱导细胞凋亡(apoptosis)。
产品编号: MS-K11020 纯度: 99.87% CAS No.: 2387505-58-8 分子式: C41H45Cl4F2N7O3 分子量: 863.65
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价

产品描述

RWJ-56110 dihydrochloride 是一种有效的、选择性的拟肽抑制剂,可抑制 PAR-1 激活和内化(结合 IC50=0.44 uM),对 PAR-2、PAR-3 和 PAR-4 无影响,并能抑制由 SFLLRN-NH2(IC50=0.16 μM)和凝血酶(IC50=0.34 μM)诱导的血小板聚集,相对于 U46619(MS-O09517)具有相当的选择性,同时在体内阻断血管生成和新血管形成,并诱导细胞凋亡(apoptosis)。

生物实验数据

生物活性 RWJ-56110 dihydrochloride is a potent and selective peptidomimetic inhibitor that inhibits PAR-1 activation and internalization (binding IC50=0.44 uM) without affecting PAR-2, PAR-3, or PAR-4, inhibits platelet aggregation induced by SFLLRN-NH2 (IC50=0.16 μM) and thrombin (IC50=0.34 μM) with comparable selectivity relative to U46619 (MS-O09517), blocks angiogenesis and neovascularization in vivo, and induces apoptosis.
IC50 & Target PAR1:0.44 uM (IC50), Platelet aggregation (human, thrombin-induced):0.34 μM (IC50), Platelet aggregation (human, SFLLRN-NH2-induced):0.16 μM (IC50)
体外研究
(In Vitro)

Proteinase-activated receptors (PARs) are a family of G protein-coupled receptors activated by the proteolytic cleavage of their N-terminal extracellular domain, exposing a new amino terminal sequence that functions as a tethered ligand to activate the receptors.
RWJ56110 inhibits the aggregation of human platelets induced by both SFLLRN-NH2 (IC50=0.16 μM) and thrombin (IC50=0.34 μM) while being quite selective relative to collagen and the thromboxane mimetic U46619 (MS-O09517).
RWJ-56110 dihydrochloride is fully inhibits thrombin-induced RASMC proliferation with an IC50 value of 3.5 μM. RWJ-56110 dihydrochloride shows blockade of thrombin’s action with RASMC calcium mobilization (IC50=0.12 μM), as well as with HMVEC (IC50=0.13 μM) and HASMC calcium mobilization (IC50=0.17 μM).
RWJ56110 (0.1-10 μM; 24-96 hours) inhibits endothelial cell growth dose-dependently, with half-maximal inhibitory concentration of RWJ56110 is approximately 10 μM.
RWJ56110 (0.1-10 μM; 6 hours) inhibits DNA synthesis of endothelial cells in a thymidine incorporation assays. Endothelial cells are in fast-growing state (50-60% confluence), RWJ56110 inhibits cell DNA synthesis in a dose-dependent manner, but when cells that are in the quiescent state (100% confluent), the inhibitory effect of PAR-1 antagonists is much less pronounced.
RWJ56110 (0.1-10 μM; pretreatment for 15 min) inhibits thrombin-induced Erk1/2 activation in a concentration-dependent manner. However, when endothelial cells are stimulated by FBS (final concentration 4%), it reduces partially the activated levels of Erk1/2.
RWJ56110 (30 μM; 24 hours) has an inhibitory effect on endothelial cell cycle progression. It reduces the percentage of cells in the S phase, while alterations in the percentages of G1 and G2/M cells are less pronounced.

Western Blot Analysis

Cell Line: Endothelial cells
Concentration: 0 μM; 3 μM; 1 μM; 3 μM; 10 μM
Incubation Time: Pretreatment for 15 min
Result: Resulted in MAPK activation in Endothelial cells.

Cell Cycle Analysis

Cell Line: Endothelial cells
Concentration: 0 μM; 3 μM; 1 μM; 3 μM; 10 μM
Incubation Time: Pretreatment for 15 min
Result: Reduced cell number in S phase.
性状 固体
颜色 White to light yellow

化学信息

分子量 863.65
分子式 C41H45Cl4F2N7O3
CAS No. 2387505-58-8

储存&溶解度

储存方式

4°C, sealed storage, away from moisture and light

*In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 200 mg/mL (231.58 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM1.1579 mL5.7894 mL11.5788 mL28.9469 mL
5 mM0.2316 mL1.1579 mL2.3158 mL5.7894 mL
10 mM0.1158 mL0.5789 mL1.1579 mL2.8947 mL
15 mM0.0772 mL0.3860 mL0.7719 mL1.9298 mL
20 mM0.0579 mL0.2895 mL0.5789 mL1.4473 mL
25 mM0.0463 mL0.2316 mL0.4632 mL1.1579 mL
30 mM0.0386 mL0.1930 mL0.3860 mL0.9649 mL
40 mM0.0289 mL0.1447 mL0.2895 mL0.7237 mL
50 mM0.0232 mL0.1158 mL0.2316 mL0.5789 mL
60 mM0.0193 mL0.0965 mL0.1930 mL0.4824 mL
80 mM0.0145 mL0.0724 mL0.1447 mL0.3618 mL
100 mM0.0116 mL0.0579 mL0.1158 mL0.2895 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础